Список литературы

1. Васильева Е.В., Вербов В.Н., Никитина И.Ю. и др. Информативность определения спонтанной и специфической продукции цитокинов для оценки активности туберкулезного процесса. Вестник уральской медицинской академической науки. 2012, 4 (41): 99-100.
2. Салина Т.Ю., Морозова Т.И. Иммунологические методы в дифференциальной диагностике. Туберкулез и болезни легких. 2011, 11: 50-53.
3. Литвинов В.И. Латентная туберкулезная инфекция - миф или реальность? Туберкулез и болезни легких. 2011, 6: 3-9.
4. Chegou N.N., Black G.F., Kidd M. et al. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med. 2009, 9 (21). - Режим доступа: - http://www.biomedcentral.com/1471-2466/9/21. - Дата обращения: 17.01.13. - Загл. с экрана.
5. Chegou N.N., Hoek K.G., Kriel M. et al. Tuberculosis assays: past, present and future. Expert Rev Anti Infect Ther. 2011, 9 (4): 457-469.
6. Diel R., Goletti D., Ferrara G. et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011, 37 (1): 88-99.
7. Kunnath-Velayudhan S., Gennaro M.L. Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. Clin Microbiol Rev. 2011, 24 (4): 792-805.
8. Metcalfe J.Z., Cattamanchi A., McCulloch C.E. et al. Test Variability of the QuantiFERON-TB Gold In-Tube Assay in Clinical Practice. Am. J. Respir. Crit. Care Med. 2013. 187 (2): 206-211.
9. Pinto L.M., Grenier J., Schumacher S.G. et al. Immunodiagnosis of Tuberculosis: State of the Art. Med. Princ Pract. 2012, 21 (1): 4-13.
10. Irina Yu. Nikitina, Natalya A. Kondratuk, George A. Kosmiadi et al. Mtb-Specific CD27low CD4 T Cells as Markers of Lung Tissue Destruction during Pulmonary Tuberculosis in Humans. PLoS One. 2012, 7 (8). - Режим доступа: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0043733. - Дата обращения: 07.02.13. - Загл. с экрана.
11. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008, 149 (3): 177-184.
12. Raja A. Immunology of tuberculosis. Indian J. Med. Res. 2004, 120 (4): 213-232.
13. Ruhwald M., Aabye M.G., Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn. 2012, 12 (2): 175-187.
14. Strieter R.M., Belperio J.A., Keane M.P. Cytokines in innate host defense in the lung. J. Clin. Invest. 2002, 109 (6): 699-705.
15. Sutherland J.S., de Jong B.C., Jeffries D.J. et al. Production of TNF-alpha, IL-12 (p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One. 2010, 5 (8). - Режим доступа: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0012365. - Дата обращения: 17.01.13. - Загл. с экрана.
16. Turgut T., Akbulut H., Deveci F. et al. Serum interleukin-2 and neopterin levels as useful markers for treatment of active pulmonary tuberculosis. Tohoku J. Exp. Med. 2006, 209 (4): 321-328.
17. Wallis R.S., Pai M., Menzies D. et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010, 375 (9729): 1920-1937.
18. Walzl G., Ronacher K., Hanekom W. et al. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 2011, 11 (5): 343-354.

Выбрать другой раздел данной публикации
Все публикации